| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 115.11M | 135.14M | 163.15M | 141.67M | 93.33M | 91.40M |
| Gross Profit | 68.25M | 83.28M | 118.03M | 92.14M | 52.58M | 51.02M |
| EBITDA | 15.28M | 29.36M | 15.77M | 14.89M | 20.90M | 28.04M |
| Net Income | 2.46M | 3.49M | -3.44M | -9.25M | 6.94M | 9.01M |
Balance Sheet | ||||||
| Total Assets | 179.94M | 173.45M | 184.51M | 195.42M | 122.57M | 122.64M |
| Cash, Cash Equivalents and Short-Term Investments | 4.06M | 3.02M | 3.13M | 1.37M | 1.80M | 5.25M |
| Total Debt | 46.25M | 45.46M | 75.50M | 74.33M | 18.45M | 20.82M |
| Total Liabilities | 125.64M | 119.99M | 130.02M | 137.23M | 50.72M | 50.55M |
| Stockholders Equity | 54.30M | 53.45M | 54.48M | 58.19M | 71.85M | 72.09M |
Cash Flow | ||||||
| Free Cash Flow | 10.36M | 20.10M | 12.24M | 6.01M | 13.71M | 13.07M |
| Operating Cash Flow | 19.80M | 29.77M | 22.98M | 12.38M | 16.48M | 15.38M |
| Investing Cash Flow | -10.64M | -11.36M | -11.63M | -32.98M | -7.44M | -2.31M |
| Financing Cash Flow | -9.07M | -18.50M | -9.48M | 18.49M | -12.51M | -11.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £50.55M | 14.63 | 38.65% | 2.69% | 30.01% | 138.65% | |
69 Neutral | £53.37M | 15.19 | 12.27% | ― | 20.40% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £185.60M | 18.70 | 4.57% | 3.01% | -31.46% | 297.44% | |
52 Neutral | £29.55M | -2.77 | -18.74% | ― | -5.84% | 55.30% | |
51 Neutral | £110.65M | 25.88 | 10.20% | 13.93% | -27.01% | -49.07% | |
50 Neutral | £12.57M | -4.40 | -67.57% | ― | -12.11% | -106.04% |